Bottom line
SMAP vs SPSM: the short answer
SMAP (Amplify Small-Mid Cap Equity ETF) and SPSM (State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF) are both etfs.
SPSM is cheaper at 0.03% vs 0.6% — a difference of $57 a year per $10,000 invested.
Over one year, SPSM returned +6.0% vs +3.7% for SMAP (reporting dates differ).
Updated Nov 19, 2026
SMAP vs SPSM side by side
| SMAP | SPSM | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Amplify | SPDR (State Street) |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 0.6% | 0.03% |
| Annual cost per $10k | $60 | $3 |
| 10-yr cost on $10k (prospectus) | $750 | $39 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +3.7% | +6.0% |
| 5-yr return (annualized) | — | +7.3% |
| 10-yr return (annualized) | — | +9.5% |
| Best quarter | +5.2% | +31.3% |
| Worst quarter | −3.3% | −32.7% |
| Net assets (fund) | — | $16.9B |
| Number of holdings | — | 613 |
| Portfolio turnover | 4% | 3% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SMAP | SPSM | Difference |
|---|---|---|---|
| 2025 | +3.7% | +6.0% | −2.4% |
Source: Fund prospectus bar charts
Holdings overlap
SMAP and SPSM share none of their top holdings.
SMAP top 10
SPSM top 10
- State Street Global Advisors — 5.85%
- FormFactor Inc — 0.68%
- Viasat Inc — 0.66%
- Molina Healthcare Inc — 0.65%
- Argan Inc — 0.60%
- BrightSpring Health Services Inc — 0.60%
- Element Solutions Inc — 0.59%
- MaxLinear Inc — 0.58%
- Krystal Biotech Inc — 0.53%
- ESCO Technologies Inc — 0.49%
FAQ
What is the difference between SMAP and SPSM?
SMAP (Amplify Small-Mid Cap Equity ETF) and SPSM (State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF) are both etfs. SPSM is cheaper at 0.03% vs 0.6% — a difference of $57 a year per $10,000 invested.
Which is cheaper, SMAP or SPSM?
SPSM has the lower expense ratio (0.03%).
Should I own both SMAP and SPSM?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.